Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. TAVR for Bicuspid AV: What’s Different?
  2. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  3. ASSURE-DES Trial
  4. 10-Year Extended Follow-up of BEST Trial
  5. Defining Lesion Severity (by Angiography, Physiology & IVUS)
  6. Not to Treat
  7. Optimal MSA for LM Crush Technique: New Criteria Any Difference in Any 2 Stent Technique?
  8. TAVR Techniques in Bicuspid Anatomy – Valve Selection, Sizing, and Positioning
  9. How to Optimize 1st Valve Choice Matter for Future
  10. How Can We Treat Patients with Concomitant Coronary Artery Disease?
  11. Low Penetration of FFR (1A Class) in Real Practice; Why and How to Overcome?
  12. Case 4. CTO
  13. CTO Revascularization 2022: Guidelines and Concept Change
  14. Physiologic Approach For Non-LM Bifurcation Disease
  15. Unmet Need for FFR in LM PCI
  16. Minimalist TAVI : Achieving Great TAVI Efficiency and Optimal Patient Outcome
  17. 타비 시술을 위한 CT 평가
  18. TAVR for Bicuspid Valve: Practical Tips and Tricks for Optimal Sizing and Positioning
  19. FFR is a Routine Cath Lab Procedure
  20. FFR, It\'s Standard
  21. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  22. Updated Imaging/Physiology-Guided PCI Tuning 2021
  23. Under Pressure: Optimal Post-Dilation Strategy
  24. Difficult Wiring, Tips and Tricks
  25. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  26. Imaging-guided PSP for Optimizing PCI
  27. How to Treat Tandem Lesion Under Physiology-Guidance
  28. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  29. Post TAVR Coronary Access with Evolut System
  30. Self-Expandable Evolut R & PRO Valve
  31. TAVR for Bicuspid AV: Tips and Tricks
  32. Bifurcation PCI: Contemporary Practical Approach
  33. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  34. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  35. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  36. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  37. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  38. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  39. Current Status of Balloon-Expandable TAVR in Korea
  40. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  41. TAVR for Bicuspid AV: Tips and Tricks
  42. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  43. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  44. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  45. Expert Case Review: Complex Bifurcation PCI
  46. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  47. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  48. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  49. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  50. How About Integrated Use of Resting Pd/Pa and FFR?
  51. Distal Left Main Bifurcation PCI: Concept Is More Important.
  52. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  53. FFR as the Gold Standard Index!
  54. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  55. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  56. Asian Pacific TAVR Registry
  57. [Taped Case] TAVR with Evolut R
  58. Bicuspid AS: Future Perspectives of TAVR
  59. Integrated Use of FFR and IVUS for LM PCI
  60. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  61. Bicuspid and Valve-in-Valve; How Different?
  62. Clinical Outcome of DEFER
  63. Left Main and MVD PCI: Imaging and Functional Guidance
  64. Utility of Intravascular Imaging for Resolving Issues During PCI
  65. Long Lesion and Tandem Lesion
  66. Bicuspid TAVR Registry
  67. AP TAVR Registry
  68. Current Status of TAVR: High/Intermediate and Lower Risk
  69. Clinical Impact of Routine FFR Measurement
  70. Tandem
  71. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  72. Practical Aspect of IMR in AMI and Stable Angina
  73. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  74. Elderly Population
  75. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  76. [Review in 2015] Physiology
  77. Tandem Lesion Evaluation
  78. Integrated Use of IVUS and FFR in Real Practice
  79. Readmission After PCI or CABG
  80. Left Main
  81. Final Answer RESTORE
  82. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  83. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  84. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  85. Preliminary Data from IRIS FFR Registry
  86. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  87. Left Main PCI
  88. Understanding About Visual-Functional Mismatching
  89. TAVI for Bicuspid Valve Stenosis
  90. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  91. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  92. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  93. Clinical Implementation of FFR
  94. Case-based Review: Incidence and Treatment of LM ISR
  95. LM & Tandem Lesion
  96. VH IVUS: Native Plaque and Neointima
  97. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  98. LM PCI
  99. IRIS-ELEMENT Data Review
  100. Cross and Perfect: 2013 Update
  101. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  102. Anatomical - Functional Stenosis: How Much Discordant?
  103. Case Presentation: Functional Angioplasty
  104. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  105. Novice's Trial of Complex LM PCI
  106. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  107. FFR Utilization in LM PCI
  108. Promus Element Clinical Program in Asan Medical Center
  109. FFR-guided PCI in Tandem Lesion
  110. Two Cases with Coronary Thromboembolism
  111. FFR Guided Functional Angioplasty
  112. Does the Timing of IABP Matter?